STAAR Surgical
STAA | NASDAQ
$26.01
-$0.38 (-1.44%)
At close: Nov 16, 2026, 4:00 PM ET
$26.01
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
STAAR Surgical Company Profile
Company profile explainedCompany Profile
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
Key Executives
| Name | Position |
|---|---|
| Warren Foust | CEO, President & Director |
| Ben Park | Chief Technology Officer |
| Connie Johnson | Director of Investor Relations |
| David Bailey | Chief Commercial Officer |
| Deborah J. Andrews | Executive VP & CFO |
| Filip De Keersmaecker | Chief Supply Chain & Quality Officer |
| Kathleen Determann | VP, Deputy General Counsel and Chief Compliance & Privacy Officer |
| Magda Michna | Chief Development Officer |
| Scott D. Barnes | Chief Medical Officer |
| William W. Goodmen | Vice President of Global Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 05, 2026 | 8-K/A | [Amend] Current Report |
| Sep 10, 2026 | 8-K | Current Report |
| Aug 18, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | 10-Q | Quarterly Report |
| Aug 12, 2026 | 8-K | Current Report |
| Aug 06, 2026 | 8-K | Current Report |
STAAR Surgical
| Country | United States |
| IPO Date | Feb 24, 1992 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 921 |
| CEO | Warren Foust |
Contact Details
25510 Commercentre Drive Lake Forest,
California 92630 United States
Stock Details
| Ticker Symbol | STAA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000718937 |
| CUSIP Number | 852312305 |
| ISIN Number | US8523123052 |
| SIC Code | 3851 |
Recent News
- 12 days ago / marketbeat.comWhat STAAR Surgical (STAA) Said on Its Q3 Earnings Call
- 12 days ago / seekingalpha.comSTAAR Surgical Company (STAA) Q3 2026 Earnings Call Transcript
- 12 days ago / zacks.comStaar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates
- 19 days ago / businesswire.comSTAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
- 20 days ago / zacks.comEarnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline
- 1 month ago / gurufocus.comSTAAR Surgical Names Andrew Pilon as Vice President of Business Development
- 2 months ago / fool.comWhy Staar Surgical Zoomed Almost 8% Higher on Tuesday
- 2 months ago / benzinga.comThis Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- 2 months ago / fool.comWhy Staar Surgical Stock Soared Today
- 2 months ago / businesswire.comSTAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
Add to Watchlist
Select watchlists to add or remove STAA